Your browser doesn't support javascript.
loading
Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis.
Cao, Runxiang; Chen, Lanlan; Liu, Yutong; Wang, Xuyutian; Ma, Ruolin; Zhao, Qian; Du, Ye.
Afiliação
  • Cao R; Breast Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China.
  • Chen L; Hepatobiliary and Pancreatic Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China.
  • Liu Y; Breast Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China.
  • Wang X; Breast Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China.
  • Ma R; Breast Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China.
  • Zhao Q; Breast Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China.
  • Du Y; Breast Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China. jdyydy@jlu.edu.cn.
J Ovarian Res ; 16(1): 215, 2023 Nov 13.
Article em En | MEDLINE | ID: mdl-37957709
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: J Ovarian Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico / Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: J Ovarian Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China